Glucocorticoid treatment and cardiovascular disease

doi:10.1136/hrt.2003.031492

Heart. 2004 August; 90(8): 829–830.

doi: 10.1136/hrt.2003.031492

PMCID: PMC1768346

Glucocorticoid treatment and cardiovascular disease

M K C Ng^* and D S Celermajer^*

Department of Medicine, University of Sydney, Australia

^*Also Heart Research Institute, Sydney, Australia

Correspondence to:
Professor David S Celermajer
Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW 2050, Australia; david.celermajer/at/email.cs.nsw.gov.au

Abstract

The propensity of glucocorticoids to produce hyperglycaemia, hypertension, dyslipidaemia, and central obesity has long been a cause for concern among physicians regarding possible adverse cardiovascular events. Should heart failure be added to this list of concerns?

Keywords: glucocorticoids, hyperglycaemia, hypertension, dyslipidaemia, heart failure

Articles from Heart are provided here courtesy of
BMJ Group